Knowing that IL-2 promotes the growth and survival of specific tumor cells [51], it is possible that the employment of these two actives at ULDs in MIM-10’s formulation might have modulated IL-2 expression and played a role in the observed reduction in the viability of the two treated cell lines. Here, IL2 is linked to neoplasm.